These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 8103086)

  • 1. Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens.
    Louis DN; Rubio MP; Correa KM; Gusella JF; von Deimling A
    J Neuropathol Exp Neurol; 1993 Sep; 52(5):507-15. PubMed ID: 8103086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
    Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
    J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas.
    Willert JR; Daneshvar L; Sheffield VC; Cogen PH
    Genes Chromosomes Cancer; 1995 Mar; 12(3):165-72. PubMed ID: 7536455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH; Bayona W; Koslow M; Newcomb EW
    Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
    Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic evidence for subtypes of oligoastrocytomas.
    Maintz D; Fiedler K; Koopmann J; Rollbrocker B; Nechev S; Lenartz D; Stangl AP; Louis DN; Schramm J; Wiestler OD; von Deimling A
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1098-104. PubMed ID: 9329453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.
    von Deimling A; Louis DN; Menon AG; von Ammon K; Petersen I; Ellison D; Wiestler OD; Seizinger BR
    Acta Neuropathol; 1993; 86(1):81-5. PubMed ID: 8103960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
    Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic alterations in radiation-induced astrocytomas.
    Brat DJ; James CD; Jedlicka AE; Connolly DC; Chang E; Castellani RJ; Schmid M; Schiller M; Carson DA; Burger PC
    Am J Pathol; 1999 May; 154(5):1431-8. PubMed ID: 10329596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
    Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP
    Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.
    Jeng YM; Hsu HC
    Int J Cancer; 2003 Jul; 105(5):625-9. PubMed ID: 12740910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations associated with glioma progression.
    Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 allelic imbalance in astrocytoma detected using fluorescent PCR of microsatellite repeat polymorphisms.
    al-Sarraj S; Bridges LR; Cawkwell L; Lewis FA; Quirke P
    Neuropathol Appl Neurobiol; 1995 Aug; 21(4):344-51. PubMed ID: 7494603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.
    van Meyel DJ; Ramsay DA; Casson AG; Keeney M; Chambers AF; Cairncross JG
    J Natl Cancer Inst; 1994 Jul; 86(13):1011-7. PubMed ID: 8007011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.